New biological platform for the production of glycoglycerolipids
In her doctoral thesis carried out in the Department of Bioengineering of IQS, Dr Núria Orive designed different metabolic engineering strategies to increase the production of glycoglycerolipids, interesting products due to their potential use as vaccine adjuvants or tumor suppressors.
Antoni Planas Sauter, PhD
Head of GQBB Group - Professor - Fellow of the Royal Academy of Sciences and Arts of Barcelona
School of Engineering
Biological and Biotechnological Chemistry
Its activity focuses on the identification and molecular analysis of proteins and enzymes as therapeutic targets, together with the design and application of enzymes in biocatalysis and biotechnology with microorganisms.